Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study.
Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study.
复制标题
DOI:
10.1080/13102818.2014.947694
复制
发表时间:
2014-09-03
期刊:
影响因子:
--
通讯作者:
Drozdzik M
中科院分区:
文献类型:
--
作者:
Vlaykova T;Kurzawski M;Tacheva T;Dimov D;Gulubova M;Yovchev Y;Chakarov S;Drozdzik M
Coetaneous malignant melanoma is the most aggressive cancer of the skin with a high rate of mortality worldwide. Degradation of basement membranes and extracellular matrix is an essential step in cancer invasion and metastasis. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play key roles in this step. MMP-3 also called stromelysin-1 was one of the first proteinases found to be associated with cancer. In the gene of MMP-3 (MMP3), an insertion/deletion of an A nucleotide at position -1171 in promoter region has been identified and shown to effect the expression activity of the gene. The present study was conducted to investigate the relation of MMP3 -1171insA polymorphism with skin malignant melanoma risk in a pilot case-control study of Bulgarian patients (n = 26) and unaffected controls (n = 172). The genotypes of controls and melanoma patients were in Hardy-Weinberg equilibrium. The results showed no statistically significant difference both in genotype and allele frequencies of MMP3 -1171insA polymorphism between melanoma patients and healthy controls either in crude analyses (p = 0.360 and 0.790, c2-test) or after adjustment for age and sex. The comparison of some clinical characteristics between the patients with different genotypes showed a trend for longer survival of patients with 6A/6A genotype compared to the carriers of 5A allele (5A/5A+5A/6A genotypes, p = 0.118, Log rank test). The results of our current preliminary study do not provide evidence for the role of the promoter polymorphism -1171insA in MMP3 as a risk factor for development of coetaneous melanoma, but suggest its implication in progression of the diseases.
登录
查看更多内容
影响因子:
3.5
作者:
Hu, Chaoliang;Wang, Jianmiao;Zhao, Jianping
通讯作者:
Zhao, Jianping
影响因子:
3.7
作者:
Zhang C;Li C;Zhu M;Zhang Q;Xie Z;Niu G;Song X;Jin L;Li G;Zheng H
通讯作者:
Zheng H
影响因子:
4.8
作者:
Ye, S;Eriksson, P;Henney, AM
通讯作者:
Henney, AM
DOI:
10.1007/s004280050443
发表时间:
1999-12-01
期刊:
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
影响因子:
--
作者:
Walker, RA;Woolley, DE
通讯作者:
Woolley, DE
影响因子:
1.2
作者:
Okamoto, Kinya;Ishida, Chihiro;Yuasa, Isao
通讯作者:
Yuasa, Isao